Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Kamen, DL"" wg kryterium: Autor


Tytuł:
Cultural and quality-of-life considerations when administering corticosteroids as a therapeutic strategy for African American women living with systemic lupus erythematosus
Autorzy:
Applyrs DL
Williams EM
Faith TD
Kamen DL
Vazquez E
Jurkowski JM
Pokaż więcej
Temat:
Systemic lupus erythematosus
African American
women
corticosteroids
quality of life
Medicine (General)
R5-920
Źródło:
Patient Preference and Adherence, Vol Volume 12, Pp 1007-1014 (2018)
Opis pliku:
electronic resource
Relacje:
https://www.dovepress.com/cultural-and-quality-of-life-considerations-when-administering-cortico-peer-reviewed-article-PPA; https://doaj.org/toc/1177-889X
Dostęp URL:
https://doaj.org/article/e1c6f2bbbb7243008170530edbce8c4c  Link otwiera się w nowym oknie
Czasopismo naukowe
Tytuł:
Smoking is not associated with autoantibody production in systemic lupus erythematosus patients, unaffected first-degree relatives, nor healthy controls.
Autorzy:
Young, KA
Terrell, DR
Guthridge, JM
Kamen, DL
Gilkeson, GS
Karp, DR
Ishimori, ML
Weisman, MH
Holers, VM
Harley, JB
Norris, JM
James, JA
Pokaż więcej
Temat:
SYSTEMIC lupus erythematosus
SMOKING
AUTOIMMUNE diseases
VASCULAR diseases
DISEASE statistics
Źródło:
Lupus; Apr2014, Vol. 23 Issue 4, p360-369, 10p, 3 Charts, 2 Graphs
Czasopismo naukowe
Tytuł:
Quality of life in patients with systemic lupus erythematosus (SLE) compared with related controls within a unique African American population.
Autorzy:
Barnado, A
Wheless, L
Meyer, AK
Gilkeson, GS
Kamen, DL
Pokaż więcej
Temat:
SYSTEMIC lupus erythematosus
QUALITY of life
AFRICAN Americans
ECONOMIC history
ECONOMICS
PATIENTS
Źródło:
Lupus; May2012, Vol. 21 Issue 5, p563-569, 7p, 4 Charts
Czasopismo naukowe
Tytuł:
Using Wii Fit to reduce fatigue among African American women with systemic lupus erythematosus: A pilot study.
Autorzy:
Yuen, HK
Holthaus, K
Kamen, DL
Sword, DO
Breland, HL
Pokaż więcej
Temat:
FATIGUE (Physiology)
NINTENDO Wii video games
HEALTH of African American women
SYSTEMIC lupus erythematosus
EXERCISE
PHYSIOLOGY
Źródło:
Lupus; Dec2011, Vol. 20 Issue 12, p1293-1299, 7p, 1 Chart
Czasopismo naukowe
Tytuł:
The United States to Africa lupus prevalence gradient revisited.
Autorzy:
Gilkeson, GS
James, JA
Kamen, DL
Knackstedt, TJ
Maggi, DR
Meyer, AK
Ruth, NM
Pokaż więcej
Temat:
SYSTEMIC lupus erythematosus
DISEASE prevalence
COMPARATIVE studies
GULLAHS
DISEASES in African Americans
SIERRA Leoneans
Źródło:
Lupus; Oct2011, Vol. 20 Issue 10, p1095-1103, 9p, 4 Charts, 2 Maps
Terminy geograficzne:
UNITED States
Czasopismo naukowe
Tytuł:
MicroRNA-3148 modulates differential gene expression of the SLE-associated TLR7variant
Autorzy:
Deng, Y
Zhao, J
Sakurai, D
Kaufman, KM
Edberg, JC
Kimberly, RP
Kamen, DL
Gilkeson, GS
Jacob, CO
Scofield, RH
Langefeld, CD
Kelly, JA
Alarcón-Riquelme, ME
Harley, JB
Vyse, TJ
Freedman, BI
Gaffney, PM
Sivils, KM
James, JA
Niewold, TB
Cantor, RM
Chen, W
Hahn, BH
Brown, EE
Tsao, BP
Pokaż więcej
Źródło:
Arthritis Research & Therapy (formerly Arthritis Research); September 2012, Vol. 14 Issue: Supplement 3
Periodyk
Tytuł:
Patient-reported disease impact of systemic lupus erythematosus with active joint symptoms: Results from the systemic lupus erythematosus-update survey.
Autorzy:
Kamen DL; Department of Medicine, 2629Medical University of South Carolina, Charleston, SC, USA.
Birt JA; Value, Evidence, and Outcomes, 1539Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN, USA.
Hadi MA; Patient Centred Research, 387388Evidera Inc, London, UK.
Gibbons E; Patient Centred Research, 387388Evidera Inc, London, UK.
Bushnell DM; Patient Centred Research, 387388Evidera Inc, Bethesda, MD, USA.
Yu R; Patient Centred Research, 387388Evidera Inc, London, UK.
Delbecque LA; Value, Evidence, and Outcomes, 1539Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN, USA.
Griffing K; Value, Evidence, and Outcomes, 1539Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN, USA.
Askanase A; Department of Rheumatology, 116366Columbia University College of Physicians and Surgeons, New York, NY, USA.
Pokaż więcej
Źródło:
Lupus [Lupus] 2022 Dec 21, pp. 9612033221147479. Date of Electronic Publication: 2022 Dec 21.
Typ publikacji:
Journal Article
Czasopismo naukowe
Tytuł:
Retinal toxicity in a multinational inception cohort of patients with systemic lupus on hydroxychloroquine.
Autorzy:
Almeida-Brasil CC; Centre for Outcomes Research and Evaluation (CORE), Research Institute of the McGill University Health Centre, Montreal, Québec, Canada.
Hanly JG; Rheumatology, Dalhousie University, Halifax, Nova Scotia, Canada.
Urowitz M; Schroeder Arthritis Institute, Krembil Research Institute, Center for Prognosis Studies in the Rheumatic Diseases, Toronto Western Hospital, University of Toronto, Toronto, Ontario, Canada.
Clarke AE; Division of Rheumatology, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.
Ruiz-Irastorza G; Autoimmune Diseases Research Unit, Biocruces Bizkaia Health Research Institute, Barakaldo, Spain.
Gordon C; Rheumatology Research Group, University of Birmingham, Birmingham, UK.
Ramsey-Goldman R; Medicine/Rheumatology, Northwestern University, Evanston, Illinois, USA.
Petri MA; Division of Rheumatology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Ginzler EM; Medicine/Rheumatology, SUNY Downstate Medical Center, New York, New York, USA.
Wallace DJ; Cedars-Sinai/David Geffen School of Medicine at UCLA, Cedars-Sinai Medical Center, Los Angeles, California, USA.
Bae SC; Rheumatology, Hanyang University Hospital for Rheumatic Diseases, Hanyang University Institute for Rheumatology and Hanyang University Institute of Bioscience and Biotechnology, Seoul, Korea.
Romero-Diaz J; Immunology and Rheumatology, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico.
Dooley MA; Medicine, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
Peschken C; Rheumatology, University of Manitoba, Winnipeg, Manitoba, Canada.
Isenberg D; Medicine (Rheumatology), University College London, London, UK.
Rahman A; Medicine (Rheumatology), University College London, London, UK.
Manzi S; Allegheny Singer Research Institute, Allegheny Health Network, Pittsburgh, Pennsylvania, USA.
Jacobsen S; Copenhagen Lupus and Vasculitis Clinic, Copenhagen University Hospital Center for Rheumatology and Spine Diseases, Copenhagen, Denmark.
Lim SS; School of Medicine, Emory University, Atlanta, Georgia, USA.
van Vollenhoven R; Department of Rheumatology, Amsterdam Rheumatology and Immunology Center, Amsterdam, The Netherlands.
Nived O; Department of Clinical Science, Rheumatology, Lund University Faculty of Medicine, Lund, Sweden.
Jönsen A; Department of Clinical Science, Rheumatology, Lund University Faculty of Medicine, Lund, Sweden.
Kamen DL; Medicine, Medical University of South Carolina, Charleston, South Carolina, USA.
Aranow C; Autoimmune and Musculoskeletal Disease, Feinstein Institute for Medical Research Fertility Research Laboratory, Manhasset, New York, USA.
Sánchez-Guerrero J; Center for Prognosis Studies in the Rheumatic Diseases, Toronto Western Hospital, Toronto, Ontario, Canada.
Gladman DD; Center for Prognosis Studies in the Rheumatic Diseases, Toronto Western Hospital, Toronto, Ontario, Canada.
Fortin PR; Medicine-Rheumatology, Universite Laval, Quebec, Quebec, Canada.
Alarcon GS; Medicine, Division of Clinical Immunology and Rheumatology, The University of Alabama at Birmingham, Birmingham, Alabama, USA.
Merrill JT; Arthritis & Clinical Immunology Program, Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma, USA.
Kalunian K; Division of Rheumatology, Allergy and Immunology, University of California San Diego, La Jolla, California, USA.
Ramos-Casals M; Department of Autoimmune Diseases, Hospital Clínic, Universitat de Barcelona, Barcelona, Spain.
Steinsson K; Rheumatology, Department of Obstetrics and Gynecology, Landspitali University Hospital, Reyjavik, Iceland.
Zoma A; Lanarkshire Centre for Rheumatology, Hairmyres Hospital, East Kilbride, UK.
Askanase AD; Rheumatology, Columbia University Medical Center, New York, New York, USA.
Khamashta M; Rayne Institute, St Thomas Hospital, London, UK.
Bruce IN; Arc Epidemiology Unit, The University of Manchester, Manchester, UK.
Inanc M; Internal Medicine Rheumatology, Istanbul University, Fatih, Istanbul, Turkey.
Lukusa L; Centre for Outcomes Research and Evaluation (CORE), Research Institute of the McGill University Health Centre, Montreal, Québec, Canada.
Bernatsky S; Centre for Outcomes Research and Evaluation (CORE), Research Institute of the McGill University Health Centre, Montreal, Québec, Canada .; Division of Rheumatology, McGill University Health Centre, Montreal, Quebec, Canada.
Pokaż więcej
Źródło:
Lupus science & medicine [Lupus Sci Med] 2022 Nov; Vol. 9 (1).
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:
Antirheumatic Agents*/adverse effects
Lupus Erythematosus, Systemic*/complications
Lupus Erythematosus, Systemic*/drug therapy
Lupus Erythematosus, Systemic*/epidemiology
Retinal Diseases*/chemically induced
Retinal Diseases*/epidemiology
Humans ; Female ; Aged ; Male ; Hydroxychloroquine/adverse effects ; Chloroquine
Czasopismo naukowe
Tytuł:
Safety, immunological effects and clinical response in a phase I trial of umbilical cord mesenchymal stromal cells in patients with treatment refractory SLE.
Autorzy:
Kamen DL; Department of Medicine, Division of Rheumatology, Medical University of South Carolina, Charleston, South Carolina, USA.
Wallace C; Department of Medicine, Division of Rheumatology, Medical University of South Carolina, Charleston, South Carolina, USA.
Li Z; Department of Medicine, Division of Hematology/Oncology, Ohio State Wexner Medical Center, Columbus, Ohio, USA.
Wyatt M; Department of Surgery, Emory University School of Medicine, Atlanta, Georgia, USA.
Paulos C; Department of Surgery, Emory University School of Medicine, Atlanta, Georgia, USA.
Wei C; University of Rochester Medical Center, Rochester, New York, USA.
Wang H; Department of Surgery, Medical University of South Carolina, Charleston, South Carolina, USA.
Wolf BJ; Department of Public Health Sciences, Medical University of South Carolina, Charleston, South Carolina, USA.
Nietert PJ; Department of Public Health Sciences, Medical University of South Carolina, Charleston, South Carolina, USA.
Gilkeson G; Department of Medicine, Division of Rheumatology, Medical University of South Carolina, Charleston, South Carolina, USA .
Pokaż więcej
Źródło:
Lupus science & medicine [Lupus Sci Med] 2022 Jul; Vol. 9 (1).
Typ publikacji:
Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural
MeSH Terms:
Lupus Erythematosus, Systemic*/drug therapy
Mesenchymal Stem Cell Transplantation*/adverse effects
Mesenchymal Stem Cells*
Female ; Humans ; Transforming Growth Factor beta ; Umbilical Cord
Czasopismo naukowe
Tytuł:
Staphylococcus aureus peptidoglycan (PGN) induces pathogenic autoantibody production via autoreactive B cell receptor clonal selection, implications in systemic lupus erythematosus.
Autorzy:
Ning W; Department of Microbiology and Immunology, Medical University of South Carolina, 173 Ashley Avenue, BSB208D, Charleston, SC, 29425, USA; Department of Rheumatology and Immunology, Xiangya Hospital, Central South University, Changsha, Hunan, China.
Cheng D; Department of Microbiology and Immunology, Medical University of South Carolina, 173 Ashley Avenue, BSB208D, Charleston, SC, 29425, USA; Department of Infectious Disease, Xiangya Hospital, Central South University, Changsha, China.
Howe PH; Department of Biochemistry and Molecular Biology, Medical University of South Carolina, SC, USA.
Bian C; Department of Microbiology and Immunology, Medical University of South Carolina, 173 Ashley Avenue, BSB208D, Charleston, SC, 29425, USA.
Kamen DL; Division of Rheumatology and Immunology, Department of Medicine, Medical University of South Carolina, 114 Doughty Street, Strom Thurmond Research Building Room 416, Charleston, SC, 29403, USA.
Luo Z; Department of Microbiology and Immunology, Medical University of South Carolina, 173 Ashley Avenue, BSB208D, Charleston, SC, 29425, USA.
Fu X; Department of Microbiology and Immunology, Medical University of South Carolina, 173 Ashley Avenue, BSB208D, Charleston, SC, 29425, USA; Department of Infectious Disease, Xiangya Hospital, Central South University, Changsha, China.
Ogunrinde E; Department of Microbiology and Immunology, Medical University of South Carolina, 173 Ashley Avenue, BSB208D, Charleston, SC, 29425, USA.
Yang L; Department of Microbiology and Immunology, Medical University of South Carolina, 173 Ashley Avenue, BSB208D, Charleston, SC, 29425, USA; The Third People's Hospital of Shenzhen, Guangdong, China.
Wang X; Department of Microbiology and Immunology, Medical University of South Carolina, 173 Ashley Avenue, BSB208D, Charleston, SC, 29425, USA; Department of Urology, Capital Medical University Affiliated XuanWu Hospital, Beijing, China.
Li QZ; Department of Immunology and Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX, USA.
Oates J; Division of Rheumatology and Immunology, Department of Medicine, Medical University of South Carolina, 114 Doughty Street, Strom Thurmond Research Building Room 416, Charleston, SC, 29403, USA; Ralph H. Johnson VA Medical Center, Charleston, SC, USA.
Zhang W; Department of Rheumatology and Immunology, Xiangya Hospital, Central South University, Changsha, Hunan, China.
White D; Department of Otolaryngology, Medical University of South Carolina, Charleston, SC, USA.
Wan Z; Department of Microbiology and Immunology, Medical University of South Carolina, 173 Ashley Avenue, BSB208D, Charleston, SC, 29425, USA.
Gilkeson GS; Division of Rheumatology and Immunology, Department of Medicine, Medical University of South Carolina, 114 Doughty Street, Strom Thurmond Research Building Room 416, Charleston, SC, 29403, USA; Ralph H. Johnson VA Medical Center, Charleston, SC, USA. Electronic address: .
Jiang W; Department of Microbiology and Immunology, Medical University of South Carolina, 173 Ashley Avenue, BSB208D, Charleston, SC, 29425, USA; Ralph H. Johnson VA Medical Center, Charleston, SC, USA; Division of Infectious Diseases, Department of Medicine, Medical University of South Carolina, Charleston, SC, USA. Electronic address: .
Pokaż więcej
Źródło:
Journal of autoimmunity [J Autoimmun] 2022 Jul; Vol. 131, pp. 102860. Date of Electronic Publication: 2022 Jul 08.
Typ publikacji:
Journal Article; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, N.I.H., Extramural
MeSH Terms:
Lupus Erythematosus, Systemic*
Staphylococcus aureus*/genetics
Animals ; Antibodies, Antinuclear ; Autoantibodies ; Cell Wall/pathology ; DNA ; Female ; Humans ; Immunoglobulin G ; Immunoglobulin M ; Mice ; Mice, Inbred C57BL ; Mice, Inbred MRL lpr ; Peptidoglycan ; Receptors, Antigen, B-Cell
Czasopismo naukowe
Tytuł:
Pre-Clinical Autoimmunity in Lupus Relatives: Self-Reported Questionnaires and Immune Dysregulation Distinguish Relatives Who Develop Incomplete or Classified Lupus From Clinically Unaffected Relatives and Unaffected, Unrelated Individuals.
Autorzy:
Munroe ME; Arthritis and Clinical Immunology Program, Oklahoma Medical Research Foundation, Oklahoma City, OK, United States.
Young KA; Department of Epidemiology, Colorado School of Public Health, Aurora, CO, United States.
Guthridge JM; Arthritis and Clinical Immunology Program, Oklahoma Medical Research Foundation, Oklahoma City, OK, United States.; Department of Medicine, Oklahoma University Health Sciences Center, Oklahoma City, OK, United States.
Kamen DL; Division of Rheumatology, Medical University of South Carolina, Charleston, SC, United States.
Gilkeson GS; Division of Rheumatology, Medical University of South Carolina, Charleston, SC, United States.
Weisman MH; Division of Rheumatology, Cedars-Sinai Medical Center, Los Angeles, CA, United States.
Ishimori ML; Division of Rheumatology, Cedars-Sinai Medical Center, Los Angeles, CA, United States.
Wallace DJ; Division of Rheumatology, Cedars-Sinai Medical Center, Los Angeles, CA, United States.
Karp DR; Division of Rheumatic Diseases, University of Texas Southwestern Medical Center, Dallas, TX, United States.
Harley JB; US Department of Veterans Affairs Medical Center, Cincinnati, OH, United States.
Norris JM; Department of Epidemiology, Colorado School of Public Health, Aurora, CO, United States.
James JA; Arthritis and Clinical Immunology Program, Oklahoma Medical Research Foundation, Oklahoma City, OK, United States.; Department of Medicine, Oklahoma University Health Sciences Center, Oklahoma City, OK, United States.; Department of Pathology, Oklahoma University Health Sciences Center, Oklahoma City, OK, United States.
Pokaż więcej
Źródło:
Frontiers in immunology [Front Immunol] 2022 Jun 03; Vol. 13, pp. 866181. Date of Electronic Publication: 2022 Jun 03 (Print Publication: 2022).
Typ publikacji:
Journal Article; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, N.I.H., Extramural
MeSH Terms:
Autoimmunity*
Lupus Erythematosus, Systemic*
Autoantibodies ; Humans ; Inflammation ; Interleukin-10 ; Self Report ; Surveys and Questionnaires ; Transforming Growth Factor beta
Czasopismo naukowe
Tytuł:
Social Factors, Epigenomics and Lupus in African American Women (SELA) Study: protocol for an observational mechanistic study examining the interplay of multiple individual and social factors on lupus outcomes in a health disparity population.
Autorzy:
Vara EL; Department of Medicine, Medical University of South Carolina, Charleston, South Carolina, USA.
Langefeld CD; Department of Biostatistics and Data Science, Wake Forest School of Medicine, Winston-Salem, North Carolina, USA.; Center for Precision Medicine, Wake Forest School of Medicine, Winston-Salem, North Carolina, USA.
Wolf BJ; Department of Public Health Sciences, Medical University of South Carolina, Charleston, South Carolina, USA.
Howard TD; Center for Precision Medicine, Wake Forest School of Medicine, Winston-Salem, North Carolina, USA.; Department of Biochemistry, Wake Forest School of Medicine, Winston-Salem, North Carolina, USA.
Hawkins GA; Center for Precision Medicine, Wake Forest School of Medicine, Winston-Salem, North Carolina, USA.; Department of Biochemistry, Wake Forest School of Medicine, Winston-Salem, North Carolina, USA.
Quet Q; Gullah/Geechee Nation, St Helena Island, South Carolina, USA.
Moultrie LH; Lee H Moultrie & Associates, North Charleston, South Carolina, USA.
Quinnette King L; Department of Medicine, Medical University of South Carolina, Charleston, South Carolina, USA.
Molano ID; Department of Medicine, Medical University of South Carolina, Charleston, South Carolina, USA.
Bray SL; Department of Medicine, Medical University of South Carolina, Charleston, South Carolina, USA.
Ueberroth LA; Department of Medicine, Medical University of South Carolina, Charleston, South Carolina, USA.
Lim SS; Department of Medicine, Emory University, Atlanta, Georgia, USA.; Department of Epidemiology, Emory University, Atlanta, Georgia, USA.
Williams EM; Department of Medicine, Medical University of South Carolina, Charleston, South Carolina, USA.; Department of Public Health Sciences, Medical University of South Carolina, Charleston, South Carolina, USA.
Kamen DL; Department of Medicine, Medical University of South Carolina, Charleston, South Carolina, USA.
Ramos PS; Department of Medicine, Medical University of South Carolina, Charleston, South Carolina, USA .; Department of Public Health Sciences, Medical University of South Carolina, Charleston, South Carolina, USA.
Pokaż więcej
Źródło:
Lupus science & medicine [Lupus Sci Med] 2022 Jun; Vol. 9 (1).
Typ publikacji:
Journal Article; Research Support, U.S. Gov't, P.H.S.; Research Support, N.I.H., Extramural
MeSH Terms:
Black or African American*/psychology
Lupus Erythematosus, Systemic*/epidemiology
Lupus Erythematosus, Systemic*/genetics
Case-Control Studies ; Cross-Sectional Studies ; Epigenomics ; Female ; Humans ; Leukocytes, Mononuclear ; Social Factors
Czasopismo naukowe
Tytuł:
Prediction of Hospitalizations in Systemic Lupus Erythematosus Using the Systemic Lupus International Collaborating Clinics Frailty Index.
Autorzy:
Legge A; Dalhousie University, Halifax, Nova Scotia, Canada.
Kirkland S; Dalhousie University, Halifax, Nova Scotia, Canada.
Rockwood K; Dalhousie University, Halifax, Nova Scotia, Canada.
Andreou P; Dalhousie University, Halifax, Nova Scotia, Canada.
Bae SC; Hanyang University Hospital for Rheumatic Diseases, Seoul, Korea.
Gordon C; College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK.
Romero-Diaz J; Instituto Nacional de Ciencias Médicas y Nutrición, Mexico City, Mexico.
Sanchez-Guerrero J; Instituto Nacional de Ciencias Médicas y Nutrición, Mexico City, Mexico.
Wallace DJ; Cedars-Sinai/David Geffen School of Medicine at University of California, Los Angeles.
Bernatsky S; McGill University, Montreal, Quebec, Canada.
Clarke AE; Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.
Merrill JT; Oklahoma Medical Research Foundation, Oklahoma City.
Ginzler EM; State University of New York Downstate Medical Center, Brooklyn.
Fortin PR; CHU de Québec-Université Laval, Quebec City, Quebec, Canada.
Gladman DD; Toronto Western Hospital and University of Toronto, Toronto, Ontario, Canada.
Urowitz MB; Toronto Western Hospital and University of Toronto, Toronto, Ontario, Canada.
Bruce IN; University of Manchester, NIHR Manchester Musculoskeletal Biomedical Research Centre, Manchester University NHS Foundation Trust, and Manchester Academic Health Science Center, Manchester, UK.
Isenberg DA; University College London, London, UK.
Rahman A; University College London, London, UK.
Alarcón GS; University of Alabama at Birmingham.
Petri M; Johns Hopkins University School of Medicine, Baltimore, Maryland.
Khamashta MA; St Thomas' Hospital, King's College London School of Medicine, London, UK.
Dooley MA; University of North Carolina, Chapel Hill.
Ramsey-Goldman R; Northwestern University and Feinberg School of Medicine, Chicago, Illinois.
Manzi S; Allegheny Health Network, Pittsburgh, Pennsylvania.
Zoma AA; Hairmyres Hospital, East Kilbride, Scotland, UK.
Aranow C; Feinstein Institute for Medical Research, Manhasset, New York.
Mackay M; Feinstein Institute for Medical Research, Manhasset, New York.
Ruiz-Irastorza G; BioCruces Bizkaia Health Research Institute, Hospital Universitario Cruces, and University of the Basque Country, Barakaldo, Spain.
Lim SS; Emory University School of Medicine, Atlanta, Georgia.
Inanc M; Istanbul Medical Faculty, Istanbul University, Istanbul, Turkey.
van Vollenhoven RF; Karolinska Institute, Stockholm, Sweden.
Jonsen A; Lund University, Lund, Sweden.
Nived O; Lund University, Lund, Sweden.
Ramos-Casals M; Hospital Clínic, Barcelona, Spain.
Kamen DL; Medical University of South Carolina, Charleston.
Kalunian KC; University of California San Diego School of Medicine, La Jolla.
Jacobsen S; Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.
Peschken CA; University of Manitoba, Winnipeg, Manitoba, Canada.
Askanase A; Hospital for Joint Diseases, New York University, New York.
Hanly JG; Queen Elizabeth II Health Sciences Center and Dalhousie University, Halifax, Nova Scotia, Canada.
Pokaż więcej
Źródło:
Arthritis care & research [Arthritis Care Res (Hoboken)] 2022 Apr; Vol. 74 (4), pp. 638-647. Date of Electronic Publication: 2022 Feb 17.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:
Frailty*/complications
Frailty*/diagnosis
Frailty*/epidemiology
Lupus Erythematosus, Systemic*/diagnosis
Lupus Erythematosus, Systemic*/epidemiology
Lupus Erythematosus, Systemic*/therapy
Adult ; Female ; Hospitalization ; Humans ; Immunosuppressive Agents/therapeutic use ; Male ; Middle Aged ; Severity of Illness Index ; Young Adult
Czasopismo naukowe
Tytuł:
Up-Regulated Interleukin-10 Induced by E2F Transcription Factor 2-MicroRNA-17-5p Circuitry in Extrafollicular Effector B Cells Contributes to Autoantibody Production in Systemic Lupus Erythematosus.
Autorzy:
Xu L; Medical University of South Carolina, Charleston, and The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China.
Wang L; The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China.
Shi Y; Medical University of South Carolina, Charleston, and The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China.
Deng Y; Medical University of South Carolina, Charleston.
Oates JC; Medical University of South Carolina, Charleston, and Ralph H. Johnson VA Medical Center, Medical Service, Charleston, South Carolina.
Kamen DL; Medical University of South Carolina, Charleston.
Gilkeson GS; Medical University of South Carolina, Charleston, and Ralph H. Johnson VA Medical Center, Medical Service, Charleston, South Carolina.
Wang F; The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China.
Zhang M; The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China.
Tan W; The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China.
Tsao BP; Medical University of South Carolina, Charleston.
Pokaż więcej
Źródło:
Arthritis & rheumatology (Hoboken, N.J.) [Arthritis Rheumatol] 2022 Mar; Vol. 74 (3), pp. 496-507. Date of Electronic Publication: 2022 Feb 09.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:
Autoantibodies*
Up-Regulation*
B-Lymphocyte Subsets/*metabolism
E2F Transcription Factors/*metabolism
Interleukin-10/*metabolism
Lupus Erythematosus, Systemic/*metabolism
Adolescent ; Adult ; Aged ; Female ; Humans ; Interleukin-10/genetics ; Leukocytes, Mononuclear/metabolism ; Lupus Erythematosus, Systemic/genetics ; Male ; MicroRNAs/genetics ; MicroRNAs/metabolism ; Middle Aged ; Young Adult
Czasopismo naukowe
Tytuł:
Evaluating the Construct of Damage in Systemic Lupus Erythematosus.
Autorzy:
Johnson SR; Schroeder Arthritis Institute, Krembil Research Institute, Toronto Western and Mount Sinai Hospitals, and Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario, Canada.
Gladman DD; Schroeder Arthritis Institute, Krembil Research Institute, Toronto Western Hospital, University of Toronto, Toronto, Ontario, Canada.
Brunner HI; Cincinnati Children's Hospital Medical Center, University of Cincinnati, Cincinnati, Ohio.
Isenberg D; University College London Centre for Rheumatology, London, UK.
Clarke AE; Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.
Barber MRW; Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.
Arnaud L; Centre National de Reference des Maladies Autoimmunes et Systemique Rares, INSERM UMR-S 1109, Université de Strasbourg, Strasbourg, France.
Fortin PR; Centre de Recherche du Centre Hospitalier Universitaire de Québec, Faculté de Médecine de l'Université Laval and Centre ARThrite, Quebec City, Quebec, Canada.
Mosca M; University of Pisa, Pisa, Italy.
Voskuyl AE; Amsterdam UMC, VUmc, Amsterdam, The Netherlands.
Manzi S; Allegheny Health Network, Lupus Center of Excellence, Pittsburgh, Pennsylvania.
Aranow C; Feinstein Institutes for Medical Research, Northwell Health, Manhasset, New York.
Askanase A; Columbia University Irving Medical Center, New York, New York.
Alarcón GS; The University of Alabama at Birmingham School of Medicine.
Bae SC; Hanyang University Hospital for Rheumatic Diseases and Hanyang University Institute for Rheumatology Research, Seoul, Republic of Korea.
Costedoat-Chalumeau N; Cochin Hospital, Université Paris Descartes-Sorbonne Paris Cité, and INSERM U 1153, Center for Epidemiology and Statistics Sorbonne Paris Cité, Paris, France.
English JA; Medical University of South Carolina, Charleston.
Pons-Estel GJ; Grupo Oroño, Centro Regional de Enfermedades Autoinmunes y Reumáticas, Sanatorio Parque, Rosario, Argentina.
Pons-Estel BA; Grupo Oroño, Centro Regional de Enfermedades Autoinmunes y Reumáticas, Sanatorio Parque, Rosario, Argentina.
Gilman R; Institute of Inflammation and Ageing, University of Birmingham, Birmingham, UK.
Ginzler EM; SUNY Downstate Health Sciences University, Brooklyn, New York.
Hanly JG; Queen Elizabeth II Health Sciences Center and Dalhousie University, Halifax, Nova Scotia, Canada.
Jacobsen S; Copenhagen Lupus and Vasculitis Clinic, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.
Kalunian K; University of California San Diego School of Medicine, La Jolla.
Kamen DL; Medical University of South Carolina, Charleston.
Lambalgen C; Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.
Legge A; Queen Elizabeth II Health Sciences Center and Dalhousie University, Halifax, Nova Scotia, Canada.
Lim SS; Emory University School of Medicine, Atlanta, Georgia.
Mak A; Yong Loo Lin School of Medicine, National University of Singapore, Singapore.
Morand EF; Monash University, Melbourne, Victoria, Australia.
Peschken CA; Max Rady College of Medicine, University of Manitoba, Winnipeg, Manitoba, Canada.
Petri M; Johns Hopkins University School of Medicine, Baltimore, Maryland.
Rahman A; University College London Centre for Rheumatology, London, UK.
Ramsey-Goldman R; Northwestern University Feinberg School of Medicine, Chicago, Illinois.
Reynolds JA; Institute of Inflammation and Ageing, University of Birmingham and Sandwell and West Birmingham National Health Service Trust, Birmingham, UK.
Romero-Diaz J; Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico.
Ruiz-Irastorza G; Biocruces Bizkaia Health Research Institute, Hospital Universitario Cruces, UPV/EHU, Barakaldo, País Vasco, Spain.
Sanchez-Guerrero J; University Health Network, Mount Sinai Hospital, University of Toronto, Toronto, Ontario, Canada, and Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico.
Svenungsson E; Karolinska Institute, Karolinska University Hospital, Stockholm, Sweden.
Touma Z; Institute of Health Policy, Management and Evaluation, Toronto Western and Mount Sinai Hospitals, University of Toronto, Toronto, Ontario, Canada.
Urowitz M; Schroeder Arthritis Institute, Krembil Research Institute, Toronto Western and Mount Sinai Hospitals, Toronto, Ontario, Canada.
Vinet E; McGill University Faculty of Medicine, Montreal, Quebec, Canada.
van Vollenhoven RF; Amsterdam University Medical Centres, Duivendrecht, Noord-Holland, The Netherlands.
Waldhauser H; Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.
Wallace DJ; Cedars-Sinai Medical Center/David Geffen School of Medicine Center at UCLA, Los Angeles, California.
Zoma A; University Hospital Hairmyres, Lanarkshire, Scotland, UK.
Bruce IN; Manchester University Hospitals National Health Service Foundation Trust, NIHR Manchester Musculoskeletal Biomedical Research Centre, Manchester Academic Health Science Centre, Manchester, Greater Manchester, UK, Centre for Epidemiology Versus Arthritis, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK.
Pokaż więcej
Źródło:
Arthritis care & research [Arthritis Care Res (Hoboken)] 2021 Dec 28. Date of Electronic Publication: 2021 Dec 28.
Typ publikacji:
Journal Article
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies

Prześlij opinię

Twoje opinie są dla nas bardzo ważne i mogą być niezwykle pomocne w pokazaniu nam, gdzie możemy dokonać ulepszeń. Bylibyśmy bardzo wdzięczni za poświęcenie kilku chwil na wypełnienie krótkiego formularza.

Formularz